Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
  • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
  • C07D471/04—Ortho-condensed systems
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
  • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
  • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
  • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
  • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
  • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
  • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
  • C07D498/04—Ortho-condensed systems
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
  • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
  • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Pharmacology & Pharmacy (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Medicinal Chemistry (AREA)
• Public Health (AREA)
• Epidemiology (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Nitrogen Condensed Heterocyclic Rings (AREA)
• Hydrogenated Pyridines (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=73598936

Family Applications (1)

Country Status (22)

Families Citing this family (64)

Family Cites Families (225)

• 2020
  • 2020-10-27 UA UAA202201759A patent/UA129778C2/uk unknown
  • 2020-10-27 GE GEAP202415960A patent/GEAP202415960A/en unknown
  • 2020-10-27 CN CN202080090232.4A patent/CN114867726B/zh active Active
  • 2020-10-27 BR BR112022007783A patent/BR112022007783A8/pt unknown
  • 2020-10-27 CR CR20220230A patent/CR20220230A/es unknown
  • 2020-10-27 CA CA3158793A patent/CA3158793A1/en active Pending
  • 2020-10-27 JP JP2022524665A patent/JP7340100B2/ja active Active
  • 2020-10-27 IL IL292438A patent/IL292438B2/en unknown
  • 2020-10-27 PH PH1/2022/551027A patent/PH12022551027A1/en unknown
  • 2020-10-27 MX MX2022005053A patent/MX2022005053A/es unknown
  • 2020-10-27 EP EP20815976.4A patent/EP4051678B1/en active Active
  • 2020-10-27 WO PCT/US2020/057496 patent/WO2021086833A1/en not_active Ceased
  • 2020-10-27 US US17/081,477 patent/US11697657B2/en active Active
  • 2020-10-27 KR KR1020227018011A patent/KR20220106980A/ko active Pending
  • 2020-10-27 GE GEAP202015960A patent/GEP20247710B/en unknown
  • 2020-10-27 PE PE2022000683A patent/PE20221253A1/es unknown
  • 2020-10-27 AU AU2020372881A patent/AU2020372881A1/en active Pending
  • 2020-10-28 TW TW109137485A patent/TWI911172B/zh active
• 2022
  • 2022-04-27 EC ECSENADI202233597A patent/ECSP22033597A/es unknown
  • 2022-04-27 DO DO2022000090A patent/DOP2022000090A/es unknown
  • 2022-05-09 JO JOP/2022/0101A patent/JOP20220101A1/ar unknown
  • 2022-05-24 CO CONC2022/0006858A patent/CO2022006858A2/es unknown
  • 2022-05-27 ZA ZA2022/05938A patent/ZA202205938B/en unknown
• 2023
  • 2023-05-03 US US18/311,639 patent/US12297208B2/en active Active
  • 2023-05-03 US US18/311,646 patent/US12291538B2/en active Active
  • 2023-08-25 JP JP2023137630A patent/JP7595127B2/ja active Active

Also Published As

Similar Documents